As the name 'Stratevi' suggests, they seamlessly combine strategy & evidence. They partner with biotechnology, pharmaceutical and medical device companies to creatively develop and communicate evidence to drive value and ensure optimal access to therapy for patients.
Novome Biotechnologies
Series A • South San Francisco, United States
Nabriva Therapeutics
Post IPO Equity • King of Prussia, United States
Adagio Therapeutics
Series C • Waltham, United States
DNAnexus
Series H • Mountain View, United States
Obsidian Therapeutics
Series B • Cambridge, United States
Dynavax Technologies
Post IPO Debt • Emeryville, United States
Shiru
Series A • Emeryville, United States
Edgewise Therapeutics
Series C • Boulder, United States
Curi Bio
Series A • Seattle, United States
Bolt Threads
Series E • Emeryville, United States
Assembly Biosciences
San Francisco, United States
Intarcia Therapeutics
Venture • Boston, United States